DK1265608T3 - Oxazolidinon tabletformulering - Google Patents

Oxazolidinon tabletformulering

Info

Publication number
DK1265608T3
DK1265608T3 DK01916186T DK01916186T DK1265608T3 DK 1265608 T3 DK1265608 T3 DK 1265608T3 DK 01916186 T DK01916186 T DK 01916186T DK 01916186 T DK01916186 T DK 01916186T DK 1265608 T3 DK1265608 T3 DK 1265608T3
Authority
DK
Denmark
Prior art keywords
oxazolidinone
tablet formulation
formulation
tablet
oxazolidinone tablet
Prior art date
Application number
DK01916186T
Other languages
English (en)
Inventor
Homer Lin
Ken Yamamoto
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22703542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1265608(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1265608T3 publication Critical patent/DK1265608T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK01916186T 2000-03-22 2001-03-15 Oxazolidinon tabletformulering DK1265608T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19096900P 2000-03-22 2000-03-22
PCT/US2001/005812 WO2001070225A2 (en) 2000-03-22 2001-03-15 Oxazolidinone tablet formulation

Publications (1)

Publication Number Publication Date
DK1265608T3 true DK1265608T3 (da) 2008-12-08

Family

ID=22703542

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01916186T DK1265608T3 (da) 2000-03-22 2001-03-15 Oxazolidinon tabletformulering

Country Status (33)

Country Link
EP (1) EP1265608B1 (da)
JP (1) JP2003527424A (da)
KR (2) KR20070094673A (da)
CN (1) CN1208058C (da)
AR (1) AR033357A1 (da)
AT (1) ATE412413T1 (da)
AU (2) AU4324301A (da)
BG (1) BG107117A (da)
BR (1) BR0108846A (da)
CA (1) CA2400118A1 (da)
CZ (1) CZ20023133A3 (da)
DE (1) DE60136341D1 (da)
DK (1) DK1265608T3 (da)
EA (1) EA006772B1 (da)
EC (1) ECSP013979A (da)
ES (1) ES2312422T3 (da)
HK (1) HK1054325B (da)
HR (1) HRP20020765A2 (da)
HU (1) HUP0300378A3 (da)
IL (1) IL151788A0 (da)
MX (1) MXPA02009316A (da)
MY (1) MY136370A (da)
NO (1) NO20024505L (da)
NZ (1) NZ521525A (da)
PE (2) PE20011126A1 (da)
PL (1) PL201686B1 (da)
PT (1) PT1265608E (da)
SK (1) SK12092002A3 (da)
TW (1) TWI293028B (da)
UA (1) UA77654C2 (da)
WO (1) WO2001070225A2 (da)
YU (1) YU69802A (da)
ZA (1) ZA200207073B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
ES2309920T3 (es) * 2005-07-20 2008-12-16 Teva Pharmaceutical Industries Ltd. Composicion farmaceutica estable que comprende la forma iii de linezolid.
WO2010026597A1 (en) * 2008-09-02 2010-03-11 Hetero Research Foundation Oral dosage forms of linezolid and processes for their preparation
ES2836809T3 (es) * 2010-11-24 2021-06-28 Melinta Subsidiary Corp Composiciones farmacéuticas
WO2013088389A1 (en) * 2011-12-14 2013-06-20 Alembic Pharmaceuticals Limited Linezolid premix
CN103505459B (zh) * 2012-06-20 2016-02-24 北京万生药业有限责任公司 利奈唑胺药物组合物
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
BR112017021097B1 (pt) 2015-04-01 2024-01-02 Akebia Therapeutics, Inc Formulação de dosagem oral e seu uso
CN106727396A (zh) * 2016-11-22 2017-05-31 湖北广济药业股份有限公司 一种ⅱ晶型利奈唑胺片及其制备方法
CN109481412A (zh) * 2018-08-17 2019-03-19 扬子江药业集团北京海燕药业有限公司 一种ii晶型利奈唑胺片及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993767A (en) * 1975-11-18 1976-11-23 A. H. Robins Company, Incorporated Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
AU767380B2 (en) * 1999-05-27 2003-11-06 Pharmacia & Upjohn Company Bicyclic oxazolidinones as antibacterial agent

Also Published As

Publication number Publication date
UA77654C2 (en) 2007-01-15
AU2001243243B2 (en) 2004-10-14
ES2312422T3 (es) 2009-03-01
AU4324301A (en) 2001-10-03
HUP0300378A2 (hu) 2003-06-28
CN1208058C (zh) 2005-06-29
CZ20023133A3 (cs) 2003-01-15
DE60136341D1 (de) 2008-12-11
HUP0300378A3 (en) 2004-11-29
EP1265608B1 (en) 2008-10-29
NZ521525A (en) 2004-02-27
WO2001070225A3 (en) 2001-12-13
PE20011126A1 (es) 2001-10-31
JP2003527424A (ja) 2003-09-16
ZA200207073B (en) 2003-12-03
TWI293028B (en) 2008-02-01
HRP20020765A2 (en) 2003-12-31
CA2400118A1 (en) 2001-09-27
ATE412413T1 (de) 2008-11-15
NO20024505D0 (no) 2002-09-20
KR20020083185A (ko) 2002-11-01
SK12092002A3 (sk) 2002-12-03
AR033357A1 (es) 2003-12-17
MXPA02009316A (es) 2004-04-05
PL201686B1 (pl) 2009-04-30
MY136370A (en) 2008-09-30
CN1418097A (zh) 2003-05-14
EA006772B1 (ru) 2006-04-28
HK1054325B (zh) 2006-01-13
BR0108846A (pt) 2003-05-06
EA200201006A1 (ru) 2003-02-27
WO2001070225A2 (en) 2001-09-27
KR100786410B1 (ko) 2007-12-17
KR20070094673A (ko) 2007-09-20
ECSP013979A (es) 2002-01-25
HK1054325A1 (en) 2003-11-28
EP1265608A2 (en) 2002-12-18
NO20024505L (no) 2002-09-20
PT1265608E (pt) 2008-12-15
IL151788A0 (en) 2003-04-10
PE20020499Z (es) 2002-07-12
BG107117A (bg) 2003-05-30
YU69802A (sh) 2005-11-28
PL366067A1 (en) 2005-01-24

Similar Documents

Publication Publication Date Title
ITTO20010008A0 (it) Formulazione farmaceutica
DK1524266T3 (da) Farmaceutisk sammensætning
NO20033384L (no) Farmasoytisk formulering
NO20003968D0 (no) Farmasøytiske preparater
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
NO20033785D0 (no) Farmasöytisk formulering
ITMI20010748A0 (it) Composizioni farmaceutiche
DE60144211D1 (de) Geteilte Peripherie-Architektur
NO20035627D0 (no) Farmasöytisk formulering
NO20026123L (no) Farmasöytiske sammensetninger
DK1331972T3 (da) Farmaceutiske præparater
DK1265608T3 (da) Oxazolidinon tabletformulering
DE60104126D1 (de) Fungizide formulierung
AR025867A1 (es) Formulacion portasdora farmaceutica
EE200200689A (et) Ravimkoostised
NO20041236L (no) Farmasoytisk formulering
NO20003408D0 (no) Tablettutleveringsanordning
SE0102957D0 (sv) Pharmaceutical formulation
SE0102069D0 (sv) Pharmaceutical formulation
SE0103565D0 (sv) Pharmaceutical formulation
SE0101325D0 (sv) Pharmaceutical formulation
SE0101326D0 (sv) Pharmaceutical formulation
SE0101171D0 (sv) Pharmaceutical formulation
SE0102572D0 (sv) Pharmaceutical formulation